Aim-Previously, we showed that radioimmunotherapy (RIT) for cryptococcal infections using radioactively labeled antibodies recognizing the cryptococcal capsule reduced fungal burden and prolonged survival of mice infected with Cryptococcus neoformans. Here, we investigate the effects of RIT on bystander mammalian cells. Results-The J774.16 and Chinese hamster ovary cells maintained membrane integrity, viability and metabolic activity following exposure to radiolabeled C. neoformans.
Cryptococcus neoformans infections are among the most difficult to treat and lethal infections in HIV-infected individuals, with cryptococcal meningitis causing approximately 600,000 deaths/year in HIV patients in sub-Saharan Africa [1] . In addition, C. neoformans is a major pathogen for individuals with an impaired immune system, including organ transplant recipients and cancer patients [2] . C. neoformans is a ubiquitous organism that is acquired from the environment by inhalation of fungal spores into the lungs. It disseminates from the lungs by passing through the epithelial cells into the bloodstream and is able to infect the brain by penetrating the blood-brain barrier [3] . Existing treatments are not very effective, require a long course of treatment and often fail to eradicate the infection and thus require life-long therapy.
In the field of medical oncology, radioimmunotherapy (RIT) uses monoclonal antibodies (mAbs), specific for tumor-associated antigens, as vectors for radionuclides. Concentrated at the tumor site, the radionuclides release their tumoricidal dose of radiation to the tumor cells. The feasibility of RIT as a tumor therapy is already established, with US FDAapproved treatments currently clinically applied to primary, relapsed or refractory B-cell non-Hodgkin's lymphomas. We have pioneered RIT for the treatment of infectious diseases, including fungal infections. RIT for infectious diseases involves the delivery of particulate radiation to the microorganisms via microorganism-specific mAbs [4] . Previous studies have shown that RIT prolongs survival and lowers fungal burden in mice infected with C. neoformans [5] . RIT was effective in infected mice on two different genetic back-grounds: the AJC/r strain with reduced immune function and immunocompetent C57Bl6 mice [6] . The residual cryptococal cells surviving post-RIT treatment in mice due to their intracellular location have been shown to be susceptible to the subsequent rounds of RIT, proving that RIT does not select for radiation-resistant mutants [7] .
The mAb 18B7, used in the current study and previous studies, is a murine monoclonal IgG1 that binds to the polysaccharide glucuronoxylomannan, a major component of the C. neoformans capsule [8] . mAb 18B7 is opsonizing, allowing phagocytic cells to recognize and ingest microbes. The cryptococcal cells can be killed by the phagocytes, while the phagocytes themselves could be killed by the cryptococcal cells. In addition, cryptococcal cells can replicate within phagocytic cells and are then extruded, without damage to either themselves or the phagocytic cell [9] . Consequently, it is important to determine whether the phagocytic cells are damaged by ingested radioactivity bound to C. neoformans. Epithelial cells could also be affected by radiation as they can take up or be invaded by C. neoformans [3] and may come into close contact with C. neoformans carrying radioactive antibodies and be killed or damaged by 'crossfire' radiation. To study the effects of particulate radiation emanating from the antibodies bound to the cryptococal capsule on epithelial and phagocytic cells, we utilized two mammalian cell lines: Chinese hamster ovary (CHO) cells, which have long been used for characterizing radiation damage, and J774.16 cells, a mouse macrophagelike line capable of nitric oxide (NO) production, which is a major component of the macrophage defensive arsenal. We employed four assays to assess the health of the mammalian cells: NO production assay; crystal violet assay as a measure of the cellular ability to proliferate; lactate dehydrogenase (LDH) assay for evaluating both cell proliferation and membrane integrity; and the tetrazolium dye (2,3)-bis-(2-methoxy-4-nitro-5-sulfenyl)-(2H)-terazolium-5-carboxanilide (XTT) assay, which is capable of assessing cellular metabolic status and is indicative of membrane integrity and mitochondrial activity. We found no evidence of damage to the epithelial or macrophagelike cells by the radiolabeled mAb bound to C. neoformans.
Materials & methods

Cells
C. neoformans strain 24067 was procured from ATCC (VA, USA). J774.16 cells are constantly maintained in our laboratories. They were propagated in Dulbecco's modified Eagle medium (DMEM)/F12 supplemented with 10% fetal bovine serum (FBS; Sigma, MO, USA) on Petri plates and passaged by scraping the cells up and diluting them into fresh media. CHO cells were obtained from the laboratory of J Pollard (Albert Einstein College of Medicine, NY, USA) and were propagated in DMEM with 10% FBS, and passaged by trypsinization. Pseudomonas oleovorans was obtained from ATCC.
Radiolabeling of 18B7 mAbs & radiolabeled mAb binding to C. neoformans cells mAb 18B7, an IgG1 recognizing the polysaccharide capsule of C. neoformans [8] , was labeled 'directly' with rhenium-188 ( 188 Re; 16.9-h physical half-life) eluted from a tungsten-188 generator (Oak Ridge National Laboratory, TN, USA) via reduction of some disulfide bonds on the antibody with dithiothreitol (Sigma), as described previously [5] . Labeling with bis-muth-213 ( 213 Bi; 46-min physical half-life) was accomplished by first attaching the ligand trans-cyclohexyldiethylenetriamine pentaacetic acid derivative CHXA-DTPA (Macrocyclics, TX, USA) to the antibody, then incubating with 213 Bi eluted from an actinium-225 generator (Institute for Transuranium Elements, Germany) [5] . For use as unlabeled controls in the cell treatment experiments, the 18B7 mAb was either treated with dithiothreitol without addition of 188 Re, or conjugated to CHXA"-DTPA without subsequent addition of 213 Bi. Following the radiolabeling, the antibodies were incubated with the heatkilled (70°C for 1 h) C. neoformans for 30 min, then the unbound antibodies were removed by centrifugation and the C. neoformans was added to the wells with the mammalian cells. We used heat-killed C. neoformans for radiation delivery in order to avoid the possible effects of viable C. neoformans on the mammalian cells, which could mask the radiation effects.
NO production
We performed several preliminary experiments to find the linear range of the assay where changes in NO concentration would be proportional to changes in cell number. Increasing the cell number from 25,000 to 75,000 cells/well produced a small increase in NO production, whereas there was a large increase in the wells with 75,000-100,000 cells ( Figure 1A ). Therefore, 100,000 cells/well were used in all experiments with the C. neoformans and mammalian cells. NO production was inhibited in the presence of aminoguanidine, an inhibitor of NO synthase, demonstrating that the nitrate measured was actually dependent on NO produced by the NO synthase ( Figure 1A ). NO production was dependent on the presence of lipopolysaccharide (Sigma) and FBS (not shown). We measured NO production at 20, 44 and 72 h in the presence of 1, 3 or 10% FBS, following addition of stimulus to the wells. With 10% FBS, NO production peaked at 24 h and declined after that. For 3% FBS, the highest levels of NO were detected at 48 h and stayed at that level up to 72 h, prompting us to use 3% FBS in the experiments with the C. neoformans and J774.16 cells.
To study the interaction of J774.16 cells with the radiation emanating from the antibodies on C. neoformans, J774.16 cells in DMEM/F12 were plated in 96-well plates at 10 5 cells/well and incubated overnight in the presence of 10% FBS and 500 U/ml IFN-γ (Cell Sciences, MA, USA) to induce adherence. On the following day, media was replaced with DMEM/ F12 without phenol red, containing 3% FBS, 500 U/ml IFN-γ and 3 µg/ml lipopolysaccharide. Heat-killed C. neoformans bound to the radiolabeled antibodies was then added to the monolayers at a multiplicity of infection (MOI) of 2. For 213 Bi-labeled C. neoformans, the supernatant was collected 48 h after addition of the C. neoformans to the wells, and for 188 Re-labeled C. neoformans, supernatant was collected at 72 h. NO has a half-life of only a few seconds, but can be converted to nitrate, which is stable in serum [10, 11] . In turn, nitrate is converted to nitrite by 90-min treatment with nitrate reductase from cell extracts of P. oleovorans, as described by Granger et al. [11] . Nitrite was measured adding Griess reagent, 1% sulfanilamide, 0.1% N-1-naphthalenediamine and 2.5% phosphoric acid. Absorbance was measured at 535 nm and nitrite concentration in the cell supernatant was calculated from a standard curve of optical density (OD) as a function of nitrite.
Crystal violet assay
To determine the linear range for the crystal violet assay, we grew monolayers in 96-well plates with increasing numbers of cells. After 24-h growth, the assay was linear from 2250 to 40,000 cells/well. After 48-h growth, dye uptake was linear from 2250 to 17,000 cells/ well; and after 72-h growth was recorded to be from 2250 to approximately 5000 cells/well ( Figure 1B) . The crystal violet uptake levels reached a plateau above the higher limits, probably because the cells had reached their growth limit.
Monolayers of CHO cells were grown up for 24 h in 96-well plates, then exposed for 12-72 h to heat-killed C. neoformans carrying radioactively labeled antibodies, at a MOI of 2. Monolayers were then washed and fixed with 100% ethanol, and crystal violet at 5% was added for 30 min, as described previously [12] . The crystal violet solution was removed and the cells were washed repeatedly in water. A total of 100 µl of ethanol was added to the wells to solubilize the crystal violet, 50 µl were removed and the OD at 595 nm was measured. For J774.16 cells, 50,000 cells/well were grown overnight, exposed to radiolabeled C. neoformans at a MOI of 2 and assayed for cell proliferation using crystal violet uptake as above.
LDH assay
Dose-response curves were generated to define the linear range of the assay as a function of starting cell number. LDH activity was very low in media from unlysed, untreated cells, and was linear as a function of cell number for wells seeded with 12,500-100,000 cells/well. To measure the total amount of LDH present within the cells, cells were lysed to release all LDH, using the lyzing reagent from the Roche Diagnostics kit (Germany). The amount of LDH in lysed cells was linear for wells seeded with 6250-50,000 cells/well for both CHO cells ( Figure 1C ) and for J774.16 cells ( Figure 1D ).
Fifty thousand J774.16 cells/well were grown overnight in 96-well plates with 500 U/ml IFN-γ to induce adherence. A total of 50,000 CHO cells/well were grown in media without IFN-γ. One hundred thousand heat-killed C. neoformans cells, with varying amounts of radioactively labeled or unlabeled 18B7 mAbs, were added to the J774. 16 or CHO cells after 24 h. The cells were incubated for another 24 h, then assayed for LDH activity using the LDH cytotoxicity detection kit from Roche Diagnostics. Controls included untreated cells, cells treated with heat-killed C. neoformans and no antibodies and cells lysed to release all LDH.
XTT assay
The XTT assay was performed as described previously, with some modifications [13] . Preliminary experiments demonstrated that the XTT assay was linear in wells that had been seeded with 2000-30,000 cells/well and grown for 24 h. After 48-h growth, there were two linear portions of the response curve, one for wells seeded with up to 12,000 cells/well, and the second portion, with a different slope, for wells seeded with 12,000-22,000 cells/well.
After 72 h, the curve was linear from 2000 to 5000 cells/well ( Figure 1E ). The variations in the values at day 3 for the wells seeded with more than 10,000 cells/well were most probably caused by some senescence of the cells. CHO cells were seeded at 10,000 cells/ well in 96-well plates in DMEM with 10% FBS and without phenol red. J774.16 cells at 10,000 cells/well were treated with 500 U/ml IFN-γ in order to make them adherent. The cells were grown up overnight, then heat-killed C. neoformans cells, at 10 5 cells/well with bound radiolabeled or unlabeled antibodies, were added and incubated for 24 h ( 213 Bi radiolabel) antibody) or 72 h ( 188 Re radiolabel). Wells were then washed and fresh media was added, along with 50 µl XTT (Sigma) at 1 mg/ml in phosphate buffered saline and 4 µl menadione (Sigma) at 1 mM in acetone. Cells were incubated for another 3 h, and the OD at 492 nm was read.
Statistical analyses
All assays were performed twice for both radionuclides, at a range of antibody concentrations, with three to six wells for each condition. The difference in the assay readouts between the various groups were analyzed by the two-tailed Student's t-test, with pvalues of <0.05 considered statistically significant.
Results & discussion
NO production, a major defense of macrophage cells, is stimulated by the presence of the polysaccharide glucuronoxylomannan, a major component of the capsule of C. neoformans, and by the presence of heat-killed C. neoformans ( Figure 1A ). Our goal was to determine whether radioactivity emanating from the radiolabeled mAbs bound to the capsule of C. neoformans ingested by phagocytic cells would alter the ability of the cells to produce NO. We found that NO production was not decreased by either 213 Bi-labeled 18B7 or 188 Relabeled 18B7 mAbs bound to heat-killed C. neoformans (Figure 2A & 2B) .
As the level of the crystal violet dye uptake reflects the total number of cells, it can be used as a measure of cell proliferation. Any treatment that interferes with the ability of the cells to replicate is expected to cause a decrease in the crystal violet uptake. We found that crystal violet staining of CHO cells was not affected by the 213 Bi-or 188 Re-labeled 18B7 antibodies delivered by heat-killed C. neoformans ( Figure 3A & 3B) . The crystal violet uptake by J774.16 cells was not affected by 213 Bi-labeled 18B7 ( Figure 3C ). We were unable to evaluate crystal violet uptake by J774.16 cells following treatment with 188 Re-labeled 18B7, as the J774.16 cells lost adherence by the 72-h time point needed for treatment with 188 Relabeled 18B7.
LDH is released from cells with leaky cell membranes and its detection in growth media is therefore indicative of cell damage. Levels of LDH released by CHO cells were not changed by the presence of heat-killed C. neoformans carrying either 213 Bi-or 188 Re-labeled 18B7, or unlabeled antibodies on its surface ( Figure 4A & 4B) . The same result was observed for J774.16 cells exposed to 213 Bi radiation ( Figure 4C ). We therefore concluded that the cells were not lysed by the radiation exposure. Similarly, the XTT assay detected no change in the reduction of XTT by CHO cells following incubation with heat-killed C. neoformans carrying either 213 Bi-or 188 Re-labeled 18B7 or unlabeled antibodies ( Figure 5A & 5B). XTT levels remained stable following the exposure of J774.16 cells to 213 Bi delivered by heatkilled C. neoformans ( Figure 5C ).
In our previous studies on RIT treatment of mice that were infected either systemically and intratrachially with C. neoformans, we did not detect radiation damage via histological analyses of their lungs and brains -the organs where C. neoformans predominantly localizes during infection [6, 14, 15] . The current study was performed to take advantage of the possibility of analyzing the early effects of bystander radiation on a large number of cells available in tissue culture, compared with the relatively few cells examined using histology following survival RIT studies in vivo. We assessed several different parameters of cell health, such as NO production, cellular ability to proliferate, membrane integrity, cellular metabolic status and mitochondrial activity. We used both the short-range α-emitter 213 Bi and the long-range β-emitter 188 Re, which have different emission ranges in tissues (µm vs mm, respectively) for labeling of the C. neoformans-specific mAbs. We expected that 188 Re might have a larger effect on mammalian cells than 213 Bi by virtue of its longer emission range. However, no assays used in this study showed any damage to the bystander cells by either radionuclide.
Strikingly, this absence of damage to the epithelial or macrophage-like cells was observed in the presence of doses of radiation that have been shown to be lethal in RIT of C. neoformans itself [16, 17] . Possible explanations for these results are the following: targeted radiation (e.g., when the radioactivity is delivered directly to the target) is more likely to kill than bystander radiation. Fungal cells are smaller targets than mammalian cells and radiation delivered to their smaller volumes could conceivably do greater damage. In the field of oncology, the radiolabeled mAbs used for the treatment of certain types of cancer, such as non-Hodgkin's lymphoma, have demonstrated their efficacy and safety in patients, in spite of very pronounced uptake in such organs as the liver, spleen or kidneys.
Conclusion
Our findings show that RIT of C. neoformans is a selective and safe treatment that has potential for translation into the clinic. -Lactate dehydrogenase assay showed that there was no damage to cell membranes, as measured by release of lactate dehydrogenase.
-XTT measurements ascertained that there was no loss of cellular energy, as measured by XTT activity.
-Nitric oxide assay demonstrated that there was no loss of the J774.16 cells' ability to make nitric oxide in response to the presence of Cryptococcus neoformans.
• RIT of C. neoformans is a selective therapy with minimal effects on host cells and these results are consistent with observations that RIT-treated mice with cryptococcal infection lacked RIT-related pathological changes in lung and brain tissues. 
